Advaxis
Clinical-stage biotechnology company developing immunotherapies for cancer and infectious diseases. Learn more
Launch date
Employees
Market cap
CAD1.2m
Enterprise valuation
CAD6m (Public information from Sep 2024)
Share price
$0.10105 ADXS
Princeton New Jersey (HQ)
Authorizing premium user...